NanoPharmaceuticals
About:
A clinical-stage company developing targeted therapeutics for cancer, inflammatory disorders, angio-proliferative diseases
Website: https://www.nanopharmaceuticals.com
Description:
Developing targeted therapeutics for cancer, inflammatory disorders, and angio-proliferative diseases.
Total Funding Amount:
$5.95M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
New York, New York, United States
Founded Date:
2013-01-01
Contact Email:
jlynch(AT)nanopharmaceuticals.com
Founders:
Paul Davis, Shaker Mousa
Number of Employees:
1-10
Last Funding Date:
2018-08-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai